Frank Rigo
Found 17 people in Ohio, Arizona, Pennsylvania and other states
Frank Rigo - @RigoRnaIt
SVP Functional Genomics & Core Research at Ionis Pharmaceuticals; RigoRnaIt Consulting; FC Barcelona ⚽️; opinions are my own.
Frank - @Frank_rigo12
FrankRigo - @FrankRigo3
Sponsored by SpokeoPaid Service
Frank J Rigo, age 76
B*****@aol.com — (914) 564-****
***** Franklin Ave, Thornwood, NY
View full reportSponsored by SpokeoPaid Service
Frank Rigo
Sponsored by PeopleLookerPaid Service
Search for contact info, city & state history, relatives, jobs, education & more
Search public records
Frank Rigo Raymundo El Diablito
AGENTE TIGO MONEY pago de recibo de luz pago de arabela pago de lecleire pago de linea tigo et
FRANK RIGO - @rigor.frank
165 followers
Frank Rigo - @frankrigo1
53 followers
KATZUMY - @frankrigo84
299 followers
Frank - @frankrigo17
142 followers
frankrigo3 - @frankrigo3
Guatemala🇬🇹🇬🇹mi país❤
57k followers
frankrigo523 - @frankrigo523
33 followers
frankrigo313 - @katzumy58
6 followers
frankmerigo - @frankmerigo
432 followers
foxtrot mike - @frankcyrus.modrigo6
32 followers
frank - @rigobertofrank3
1,302 followers
FrankM - @frankpedongmodrigo
🇵🇭🇵🇭@atin ang wps 🥰🤣🇵🇭🇵🇭
1,312 followers
Frank Rigo - @frankrigo4753
This channel contains songs and testimonies about our walk down life's road with Jesus Christ. There are instrumental versions of ...
19 subscribers
Frank Rigo - Topic
2 subscribers
Frank Rigo - @frankrigo6072
1 subscriber
FrankRigo - @FrankRigo
1 subscriber
rigofrank - @rigofrank
1 subscriber
Frank Bonarrigo Dj - @frankrigodj
12 subscribers
Frank Rigo
Writer - Freelance, self-employed
Frank Rigo
Frank Rigo
Xiulong (Mark) Shen
Entrada Therapeutics
Mark Fang
MD/PhD student - UCSD School of Medicine
Jianrong Tang
Baylor College of Medicine
Dustin Goncharoff
Sarah DeVos
Curie.Bio
Huimin Zhang
University of California, Riverside
Laurent Bogdanik
Associate Director, Preclinical Services ...
Anita Nag
Assistant Professor of Chemistry - USC Upstate
Matthew Spalitta
Medical Assistant - Harry Tompson Rebuild ...
Daniel Ramos
Postdoctoral Researcher - The National Institutes of ...
Catherine Wu
Herman Ostrow School of Dentistry of USC
Katerina Dague, M.S.
Transnetyx
Frank Rigo
-
Lorain High School (1977 - 1981)
Lorain, OH
Frank Rigo
-
Maryvale High School (1975 - 1979)
Cheektowaga, NY
Frank Rigo
-
Princess Margaret Secondary School (1972 - 1976)
Vancouver, BC
Francis Rigo Jr
-
St. Catharine Elementary School (1962 - 1966)
Pelham, NY
Frank Rigo
Sponsored by PeopleLookerPaid Service
Search for Frank Rigo's city and state history
Search address historyC. Frank Bennett
Breakthrough Prize - Thu, 18 Oct 2018
Sarm1 haploinsufficiency or low expression levels after antisense oligonucleotides delay programmed axon degeneration
ScienceDirect.com - Tue, 14 Dec 2021
Tau seeds are subject to aberrant modifications resulting in distinct signatures
ScienceDirect.com - Tue, 27 Apr 2021
MaTAR25 lncRNA regulates the Tensin1 gene to impact breast cancer progression
Nature - Tue, 22 Dec 2020
Mammary Tumor-Associated RNAs Impact Tumor Cell Proliferation, Invasion, and Migration
ScienceDirect.com - Tue, 27 Sep 2016
frank rigo - @heelandhoseboi
0 photos - 0 followers
frank rigo - @morvou6
365 followers
Frank Rigo - @roofsuperstar44
0 followers
frank rigo - @morvouzette12
13 followers
Frank Rigo Sr. - @frankrigosr
2 followers
Frank Rigo - @frank_rigo
0 followers
Frank Rigo - @fri44596
0 followers
Frank Rigo - @frankrigo7543
0 followers
Frank Rigo - @paco1706
0 followers
frank rigo - @frankrigo
0 followers
Rigo Frank - @frankrigo83
0 followers
Frankrigo - @frankrigo8555
0 followers
Frank Rigo, PhD - Oligonucleotide Therapeutics Society
https://www.oligotherapeutics.org/.../f…
Frank Rigo - Google Scholar
2017. Pharmacology of a central nervous system delivered 2′-O-methoxyethyl–modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primates. F Rigo, SJ Chun, DA Norris, G Hung, S Lee, J Matson, RA Fey, H Gaus, ... Journal of Pharmacology and Experimental Therapeutics 350 (1), 46-55.
Frank Rigo's research works | Ionis Pharmaceuticals, Carlsbad and …
Frank Rigo's 181 research works with 10,855 citations and 16,113 reads, including: Modulation of Gene Expression in the Eye with Antisense Oligonucleotides.
2015 OTS Young Investigator Award Winner Frank Rigo, PhD
Frank Rigo, PhD. Ionis Pharmaceuticals, Inc. Biography: In 2002, Frank completed his undergraduate studies in molecular biology and biochemistry at Marquette University. From 2002-2008, Frank earned his Ph.D. at UCLA in the Biochemistry Department under Harold Martinson.
Frank Rigo - Wikipedia
Frank Rigo (c. 1868 – 5 August 1936) was an American director of grand opera who had a substantial career in Australia, where he died penniless, leaving an orphaned daughter. History. Rigo was born in America and grew up in New York, where he developed a …
Frank Rigo, Ph.D. | Ionis Pharmaceuticals, Inc.
©1989 – 2024 Ionis Pharmaceuticals® is a registered trademark of Ionis Pharmaceuticals, Inc. Akcea Therapeutics® is a wholly owned subsidiary of Ionis ...
Towards a therapy for Angelman syndrome by targeting …
Frank Rigo. Nature 518 , 409–412 ( 2015) Cite this article. 26k Accesses. 343 Citations. 85 Altmetric. Metrics. Angelman syndrome is a single-gene disorder characterized by intellectual...
Antisense oligonucleotides as a potential treatment for brain deficits …
Myotonic dystrophy, or dystrophia myotonica type 1 (DM1), is a multi-systemic disorder and is the most common adult form of muscular dystrophy. It affects not only muscles but also many organs, including the brain. Cerebral impairments include cognitive deficits, daytime sleepiness, and loss of visu …
Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to ...
Authors. Frank Rigo 1 , Yimin Hua , Seung J Chun , Thazha P Prakash , Adrian R Krainer , C Frank Bennett. Affiliation. 1 Isis Pharmaceuticals, Carlsbad, California, USA. PMID: 22504300. PMCID: PMC5021312. DOI: 10.1038/nchembio.939. Abstract.
Author Correction: Systematic screening identifies therapeutic
Frank Rigo & Tom Misteli. Nature Medicine 27 , 1309 ( 2021) Cite this article. 1 Citations. Metrics. The Original Article was published on 11 March 2021. Correction to: Nature Medicine...
Antisense oligonucleotide therapy for SCN2A gain-of-function
Paymaan Jafar-Nejad and Frank Rigo are employees of Ionis Pharmaceuticals. The clinical spectrum associated with SCN2A de novo mutations (DNMs) continues to expand and includes autism spectrum disorder with or without seizures, in addition to early and late seizure onset developmental and epileptic encephalopathies (DEEs).
Antisense oligonucleotide-based therapies for diseases caused by …
Frank Rigo 1 , Punit P Seth, C Frank Bennett. Affiliation 1 Isis Pharmaceuticals, 2855 Gazelle Court, Carlsbad, CA, USA, FRigo@isisph.com. PMID: 25201110 DOI: 10.1007/978-1-4939-1221-6_9 Abstract Before a messenger RNA (mRNA) is translated into a protein in the cytoplasm, its pre-mRNA precursor is extensively processed through capping, splicing ...
Robust transcriptome-wide discovery of RNA-binding protein
Frank Rigo, Mitchell Guttman & Gene W Yeo. Nature Methods 13 , 508–514 ( 2016) Cite this article. 69k Accesses. 679 Citations. 60 Altmetric. Metrics. Abstract.
Directed RNase H Cleavage of Nascent Transcripts Causes …
Frank Rigo Correspondence flai@ionisph.com (F.L.), frigo@ionisph.com (F.R.) In Brief Lai et al. show that ASO-directed RNase H1-dependent cleavage and degradation of nascent transcripts causes RNA Pol II transcription termination. They demonstrate that judicious design of ASOs allows for transcript degradation without affecting transcription ...
Frank Rigo, Ionis Pharmaceuticals Inc: Profile and Biography
Frank Rigo is Senior VP:Functional Genomics at Ionis Pharmaceuticals Inc. See Frank Rigo's compensation, career history, education, & memberships.
JCI - Antisense oligonucleotide therapy reduces seizures and …
After several decades of development, antisense oligonucleotides (ASOs) have recently been approved as a treatment for spinal muscular atrophy and Duchenne muscular dystrophy, which demonstrated that RNA-targeted therapies are a viable therapeutic strategy for these devastating neurogenetic disorders ( 5, 6 ).
Antisense Oligonucleotide-Mediated Removal of the ... - PubMed
Lodewijk J A Toonen 1 , Frank Rigo 2 , Haico van Attikum 1 , Willeke M C van Roon-Mom 3 Affiliations 1 Department of Human Genetics, Leiden University Medical Center, Albinusdreef 2, 2333ZA Leiden, the Netherlands. 2 Ionis Pharmaceuticals, Carlsbad, CA 92008, USA. 3 Department of Human Genetics, Leiden University Medical Center, …
Frank Rigo's research works | Ionis Pharmaceuticals, Carlsbad and …
Frank Rigo's research works | Ionis Pharmaceuticals, Carlsbad and other places. Frank Rigo's research while affiliated with Ionis Pharmaceuticals and other places. What is this page?...
Frank Rigo - Vice President, Functional Genomics & Drug ... - Wiza
Frank Rigo is based out of Carlsbad, California, United States and works at Ionis Pharmaceuticals, Inc. as Vice President, Functional Genomics & Drug Discovery. Reveal contact info. Contact info and email address. Work email. f*****@ionisp***.com. Valid. Reveal. Latest update. January 23, 2024. Location. Carlsbad, California, United States.
Directed RNase H Cleavage of Nascent Transcripts Causes
Directed RNase H Cleavage of Nascent Transcripts Causes Transcription Termination Mol Cell. 2020 Mar 5 ... Fan Lai 1 , Sagar S Damle 2 , Karen K Ling 2 , Frank Rigo 3 Affiliations 1 Ionis Pharmaceuticals, Carlsbad, CA 92010, USA. Electronic address: flai@ionisph.com. 2 Ionis Pharmaceuticals, Carlsbad, CA 92010, USA. 3 Ionis …
Frank Rigo: Molecular Biology H-index & Awards - Research.com
Discover the latest information about Frank Rigo - D-Index & Metrics, Awards, Achievements, Best Publications and Frequent Co-Authors. Molecular Biology scholar academic profile.
Functional coupling of last-intron splicing and 3'-end ... - PubMed
Frank Rigo 1 , Harold G Martinson. Affiliation. 1 Department of Chemistry and Biochemistry, University of California at Los Angeles, Los Angeles, CA 90095-1569, USA. PMID: 17967872. PMCID: PMC2223410. DOI: 10.1128/MCB.01410-07. Abstract.